PLUS THERAPEUTICS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Plus Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Plus Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -285 %, a 178% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -285 -650 -178% Sep 30, 2024
Q2 2024 -471 -702 -304% Jun 30, 2024
Q1 2024 -5.04K -5.21K -2934% Mar 31, 2024
Q4 2023 724 +604 +504% Dec 31, 2023
Q3 2023 365 +270 +284% Sep 30, 2023
Q2 2023 231 +146 +171% Jun 30, 2023
Q1 2023 178 +101 +132% Mar 31, 2023
Q4 2022 120 +37.4 +45.3% Dec 31, 2022
Q3 2022 95.2 +1.44 +1.54% Sep 30, 2022
Q2 2022 85.4 -46.8 -35.4% Jun 30, 2022
Q1 2022 76.5 -127 -62.4% Mar 31, 2022
Q4 2021 82.6 -466 -85% Dec 31, 2021
Q3 2021 93.7 -780 -89.3% Sep 30, 2021
Q2 2021 132 -1.55K -92.1% Jun 30, 2021
Q1 2021 203 +1.92K Mar 31, 2021
Q4 2020 549 +8.15K Dec 31, 2020
Q3 2020 873 -1.83K -67.7% Sep 30, 2020
Q2 2020 1.68K +853 +103% Jun 30, 2020
Q1 2020 -1.72K -2.1K -546% Mar 31, 2020
Q4 2019 -7.6K -7.9K -2618% Dec 31, 2019
Q3 2019 2.71K +2.48K +1082% Sep 30, 2019
Q2 2019 828 +613 +285% Jun 30, 2019
Q1 2019 385 +196 +103% Mar 31, 2019
Q4 2018 302 +96.6 +47.1% Dec 31, 2018
Q3 2018 229 -0.79 -0.34% Sep 30, 2018
Q2 2018 215 +6.22 +2.97% Jun 30, 2018
Q1 2018 189 +5.52 +3.01% Mar 31, 2018
Q4 2017 205 +17.6 +9.39% Dec 31, 2017
Q3 2017 230 +42.9 +22.9% Sep 30, 2017
Q2 2017 209 -47.5 -18.5% Jun 30, 2017
Q1 2017 184 -303 -62.3% Mar 31, 2017
Q4 2016 188 +4.68K Dec 31, 2016
Q3 2016 187 +1.05K Sep 30, 2016
Q2 2016 257 +873 Jun 30, 2016
Q1 2016 487 +1.06K Mar 31, 2016
Q4 2015 -4.49K -1.64K -57.3% Dec 31, 2015
Q3 2015 -861 -5.19K -120% Sep 30, 2015
Q2 2015 -617 -4.9K -114% Jun 30, 2015
Q1 2015 -572 -4.81K -114% Mar 31, 2015
Q4 2014 -2.85K -6.96K -169% Dec 31, 2014
Q3 2014 4.33K +2.23K +106% Sep 30, 2014
Q2 2014 4.28K -37.5K -89.8% Jun 30, 2014
Q1 2014 4.24K +45.6K Mar 31, 2014
Q4 2013 4.11K +207 +5.3% Dec 31, 2013
Q3 2013 2.1K -76.9 -3.54% Sep 30, 2013
Q2 2013 41.8K +41.2K +7210% Jun 30, 2013
Q1 2013 -41.4K -41.8K -9789% Mar 31, 2013
Q4 2012 3.9K Dec 31, 2012
Q3 2012 2.17K Sep 30, 2012
Q2 2012 572 Jun 30, 2012
Q1 2012 427 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.